Biosynth Carbosynth and vivitide logos

KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder

Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end-markets.

Read press release here...

 

Biosynth vivitide post image